Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders

 
 

Sunovion Pharmaceuticals Inc. (SEPR) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $17.60 Metrics
OS: 112.0 M 22 % ROE
Market cap: $1.97 B 28 % ROIC
Net cash: $421 M $3.76 per share
EV: $1.55 B

 
TTM Valuation
EBITDA $308 M 5.0 x EV/EBITDA
EBIT $272 M 5.7 x EV/EBIT
EPS $1.64 10.8 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02Dec-31-01
Revenues1,292.31,225.21,183.1801.1380.9344.0239.0152.1
            Revenue growth5.5%3.6%47.7%110.3%10.7%44.0%57.1%78.4%
Cost of goods sold130.3115.8103.866.734.528.923.415.4
Gross profit1,162.01,109.41,079.4734.4346.4315.2215.6136.7
            Gross margin89.9%90.5%91.2%91.7%91.0%91.6%90.2%89.9%
Sales and marketing654.1699.3691.7585.8358.0173.0155.2111.7
Research and development246.8263.8163.5144.5160.0220.2243.8231.3
General and administrative106.481.471.940.831.425.922.719.7
EBITA61.463.1150.9-38.1-205.4-107.2-208.8-228.1
            EBITA margin4.8%5.2%12.8%-4.8%-53.9%-31.2%-87.4%-150.0%
Amortization of intangibles7.40.20.2     
EBIT54.162.9150.7-38.1-205.4-107.2-208.8-228.1
            EBIT margin4.2%5.1%12.7%-4.8%-53.9%-31.2%-87.4%-150.0%
Pre-tax income68.464.6174.8-15.7-296.9-137.9-276.5-226.2
Income taxes-446.76.33.70.20.00.00.0-2.2
            Tax rate 9.7%2.1% 0.0%0.0%0.0%1.0%
Net income515.158.3171.2-15.9-296.90.0-276.5-224.0
            Net margin39.9%4.8%14.5%-2.0%-78.0%0.0%-115.7%-147.3%
 
Diluted EPS$4.47$0.50$1.48($0.15)($3.23)$0.00($3.34)($2.89)
Shares outstanding (diluted)115.3116.4115.5104.892.084.682.977.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy